GW PHARMACEUTICALS PLC Payments to Acquire Software
GW PHARMACEUTICALS PLC reported Payments to Acquire Software of $2.89 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireSoftware · last filed 2021-05-03
- GW PHARMACEUTICALS PLC payments to acquire software for the quarter ending 2021-03-31 was $2.89M, a 440.00% increase year-over-year.
- GW PHARMACEUTICALS PLC payments to acquire software for the quarter ending 2020-12-31 was $653.00K, a 28.94% decline year-over-year.
- GW PHARMACEUTICALS PLC payments to acquire software for the quarter ending 2020-09-30 was $910.00K, a 448.19% increase year-over-year.
- GW PHARMACEUTICALS PLC payments to acquire software for the quarter ending 2020-06-30 was $920.00K, a 12.47% increase year-over-year.
- GW PHARMACEUTICALS PLC payments to acquire software for fiscal 2020 was $3.02M, a 43.58% increase from fiscal 2019.
- GW PHARMACEUTICALS PLC payments to acquire software for fiscal 2019 was $2.10M.
- GW PHARMACEUTICALS PLC payments to acquire software for fiscal 2018 was $2.04M.
| Period end | Payments to Acquire Software 3 month | Payments to Acquire Software 6 month | Payments to Acquire Software 9 month | Payments to Acquire Software 12 month |
|---|---|---|---|---|
| 2021-03-31 | $2.89M 10-Q · filed 2021-05-03 | $3.54M derived: sum of 2 quarters · filed 2021-05-03 | $4.45M derived: sum of 3 quarters · filed 2021-05-03 | $5.37M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-12-31 | $653.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $1.56M derived: sum of 2 quarters · filed 2021-02-26 | $2.48M derived: sum of 3 quarters · filed 2021-02-26 | $3.02M 10-K · filed 2021-02-26 |
| 2020-09-30 | $910.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.83M derived: sum of 2 quarters · filed 2020-11-05 | $2.37M 10-Q · filed 2020-11-05 | $3.28M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | $920.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $1.46M 10-Q · filed 2020-08-07 | $2.37M derived: sum of 3 quarters · filed 2021-05-03 | $2.54M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | $535.00K 10-Q · filed 2021-05-03 | $1.45M derived: sum of 2 quarters · filed 2021-05-03 | $1.62M derived: sum of 3 quarters · filed 2021-05-03 | $2.44M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $919.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $1.08M derived: sum of 2 quarters · filed 2021-02-26 | $1.90M derived: sum of 3 quarters · filed 2021-02-26 | $2.10M 10-K · filed 2021-02-26 |
| 2019-09-30 | $166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $984.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.18M 10-Q · filed 2020-11-05 | $1.25M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $818.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $1.02M 10-Q · filed 2020-08-07 | $1.08M derived: sum of 3 quarters · filed 2021-02-26 | |
| 2019-03-31 | $199.00K 10-Q · filed 2020-05-11 | $262.00K derived: sum of 2 quarters · filed 2021-02-26 | ||
| 2018-12-31 | $63.00K 10-K · filed 2021-02-26 | |||
| 2018-09-30 | $2.04M 10-K · filed 2021-02-26 | |||
| 2017-12-31 | $993.00K 10-K · filed 2021-02-26 |